Drawing for MEDICINES360 ASPIRE

USPTO serial 99491156

MEDICINES360 ASPIRE

Reviewed by CopyMark Law Group

Status 681
Filing date
Status date
Registration date
—
Examiner
BEVERLY, JOSETTE MICHELLE
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with MEDICINES360 ASPIRE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Cecily Anne O'Regan

Cecily Anne O'Regan Vitruvian IP Law LLC31 Teaticket Highway Suite 107East Falmouth, MA 02536United States

Goods and services

ClassDescriptionStatusFirst use
001Reagents and assays for scientific and research useACTIVE—
005Medical reagents and assays; Medical diagnostic reagents and assays; reagents and assays for use in treating, monitoring, testing, analyzing and detecting medical conditions, diseases and disorders in the field of women’s health, men’s health, cardiology, endocrinology, gynecology, immunology, oncology, ophthalmology, hematology, infectious disease, gastroenterology, neurology, urology, dermatology, reproduction, infertility, pregnancy, contraception, proteomics and diabetes; diagnostic biomarker reagents and assays for medical purposesACTIVE—
035Promoting awareness of and organizing and developing projects to support women’s healthACTIVE—
041Educational services, namely, conducting classes, seminars, conferences, workshops, and online webinars for physicians and other medical service providers to provide instruction on the use of software and medical reagents and assays, and distribution of training materials in connection therewithACTIVE—
042Providing medical and scientific research information in the field of women’s health, men’s health, cardiology, endocrinology, gynecology, immunology, oncology, ophthalmology, hematology, infectious disease, gastroenterology, neurology, urology, dermatology, reproduction, infertility, pregnancy, contraception, proteomics and diabetes; Providing online non-downloadable software for medical diagnostic testing or treatment; Software as a service (SAAS) services featuring software for medical assessment, diagnostic testing or treatment; Providing online non-downloadable software, for medical testing, reports for risk prediction and classification and information in the field of maternal health and health conditions during pregnancy and laborACTIVE—
044Providing medical information in the field of women’s health, men’s health, cardiology, endocrinology, gynecology, immunology, oncology, ophthalmology, hematology, infectious disease, gastroenterology, neurology, urology, dermatology, reproduction, infertility, pregnancy, contraception, proteomics and diabetes; Medical diagnostic testing, monitoring and reporting services; providing medical information in the field of medical testing, risk prediction and classification of maternal health conditions and health conditions during pregnancy and laborACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 15, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 23, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Sep 23, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Sep 23, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 29, 2026XELGAPPLICATION EXTENSION GRANTED/RECEIPT PROVIDED—
Jun 29, 2026XELRAPPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED—
May 14, 2026TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
May 14, 2026ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 14, 2026REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
May 14, 2026CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
May 14, 2026COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Apr 1, 2026GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 1, 2026GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 1, 2026CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 21, 2026DOCKASSIGNED TO EXAMINER—
Mar 8, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 12, 2026EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Feb 12, 2026TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Feb 12, 2026ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 12, 2026REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Nov 11, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
Nov 11, 2025NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance